Trop2 gene: A novel target for cervical cancer treatment

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 8, 2014, Pages 1331-1341

  Liu, Xiaoqi ^a   Li, Siqi ^a   Yi, Faping ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cervical cancer; Proliferation; RNAi; Trop2

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN D1; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; SHORT HAIRPIN RNA;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; COLONY FORMATION; DOWN REGULATION; ENZYME ACTIVITY; GENE; GENE TARGETING; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TROP2 GENE; UPREGULATION; UTERINE CERVIX CANCER;

ANTIGENS, NEOPLASM; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; RNA, MESSENGER; RNA, SMALL INTERFERING; UTERINE CERVICAL NEOPLASMS;

EID: 84904365036     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-014-1696-1     Document Type: Article

References (51)

1. Alemany L, de Sanjosé S, Tous S, Quint W, Vallejos C, Shin HR, Bravo LE, Alonso P, Lima MA, Guimerà N, Klaustermeier J, Llombart-Bosch A, Kasamatsu E, Tatti SA, Felix A, Molina C, Velasco J, Lloveras B, Clavero O, Lerma E, Laco J, Bravo IG, Guarch R, Pelayo A, Ordi J, Andújar M, Sanchez GI, Castellsagué X, Muñoz N, Bosch FX, on Behalf of the RIS HPV T Study Group (2014) Time trends of human papillomavirus types in invasive cervical cancer, from 1940 to 2007. Int J Cancer 135(1):88-95
2. Bignotti E, Ravaggi A, Romani C, Falchetti M, Lonardi S, Facchetti F, Pecorelli S, Varughese J, Cocco E, Bellone S, Schwartz PE, Rutherford TJ, Santin AD (2011) Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody. Int J Gynecol Cancer 21(9):1613-1621
3. Brewer NT, Chung JK, Baker HM, Rothholz MC, Smith JS (2014) Pharmacist authority to provide HPV vaccine: novel partners in cervical cancer prevention. Gynecol Oncol 132(Suppl 1):S3-S8
4. Calabrese G, Crescenzi C, Morizio E, Palka G, Guerra E, Alberti S (2001) Assignment of TACSTD1 (alias TROP1, M4S1) to human chromosome 2p21 and refinement of mapping of TACSTD2 (alias TROP2, M1S1) to human chromosome 1p32 by in situ hybridization. Cytogenet Cell Genet 92(1-2):164-165 (Pubitemid 32304683)
5. Chang CH, Gupta P, Michel R, Loo M, Wang Y, Cardillo TM, Goldenberg DM (2010) Ranpirnase (Frog RNase) targeted with a humanized, internalizing, anti-Trop-2 antibody has potent cytotoxicity against diverse epithelial cancer cells. Mol Cancer Ther 9(8):2276-2286
6. Crum CP, Ikenberg H, Richart RM, Gissman L (1984) Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med 310(14):880-883 (Pubitemid 14173180)
7. Cubas R, Li M, Chen C, Yao Q (2009) Trop2: a possible therapeutic target for late stage epithelial carcinomas. Biochim Biophys Acta 1796(2):309-314
8. Dijkstra MG, Snijders PJ, Arbyn M, Rijkaart DC, Berkhof J, Meijer CJ (2014) Cervical cancer screening: on the way to a shift from cytology to full molecular screening. Ann Oncol 25(5):927-935
9. Fadare O, Reddy H, Wang J, Hileeto D, Schwartz PE, Zheng W (2005) E-cadherin and β-catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases. World J Surg Oncol 3:38-48
10. Ferenczy A, Braun L, Shah KV (1981) Human papillomavirus (HPV) in condylomatous lesions of cervix. Am J Surg Pathol 5(7):661-670
11. Fong D, Moser P, Krammel C, Gostner JM, Margreiter R, Mitterer M, Gastl G, Spizzo G (2008a) High expression of TROP2 correlates with poor prognosis in pancreatic cancer. Br J Cancer 99(8):1290-1295
12. Fong D, Spizzo G, Gostner JM, Gastl G, Moser P, Krammel C, Gerhard S, Rasse M, Laimer K (2008b) TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 21(2):186-191 (Pubitemid 351172170)
13. Fornaro M, Dell'Arciprete R, Stella M, Bucci C, Nutini M, Capri MG, Alberti S (1995) Cloning of the gene encoding Trop-2, a cell-surface glycoprotein expressed by human carcinomas. Int J Cancer 62(5):610-618
14. Gravitt PE, Shah KV (2005) A virus-based vaccine may prevent cervical cancer. Curr Infect Dis Rep 7(2):125-131
15. Guerra E, Trerotola M, Dell' Arciprete R, Bonasera V, Palombo B, El-Sewedy T, Ciccimarra T, Crescenzi C, Lorenzini F, Rossi C, Vacca G, Lattanzio R, Piantelli M, Alberti S (2008) A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer. Cancer Res 68(19):8113-8121
16. Guerra E, Trerotola M, Aloisi AL, Tripaldi R, Vacca G, La Sorda R, Lattanzio R, Piantelli M, Alberti S (2013) The Trop-2 signalling network in cancer growth. Oncogene 32(12):1594-1600
17. Hariri S, Markowitz LE, Dunne EF, Unger ER (2013) Population impact of HPV vaccines: summary of early evidence. J Adolesc Health 53(6):679-682
18. Hsu EM, McNicol PJ (1992) Characterization of HPV-16 E6/E7 transcription in CaSki cells by quantitative PCR. Mol Cell Probes 6(6):459-466
19. Hussa RO, Maruo T, Strobel JL, Pattillo RA, Mochizuki M (1986) Production of tumor-associated antigen, TA-4, by the CaSki cervical carcinoma cell line. Obstet Gynecol 67(6):802-805 (Pubitemid 16060041)
20. Jares P, Pl Fernandez, Campo E, Nadal A, Bosch F, Aiza G, Nayach I, Traserra J, Cardesa A (1994) PRAD-1/cyclinD1 gene amplification correlates with messenger RNA over-expression and tumor progression in human laryngeal carcinomas. Cancer Res 54(17):4813-4817
21. Jianbo W, Ryan D, Yiyu D, Weintraub SJ, Michel L (2008) Identification of Trop-2 as an oncogene and an attractive therapeutic target in colon cancers. Mol Cancer Ther 7(2):280-285 (Pubitemid 351302522)
22. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275(5303):1132-1136 (Pubitemid 27097313)
23. Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD, Kornbluth S (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 273(26):16589-16594 (Pubitemid 28311447)
24. Li X, Hao Z, Fan R, Zou X, Jin H, Pan Y, He L, Du R, Gao L, Liu D, Fan D (2007) CIAPIN1 inhibits gastric cancer cell proliferation and cell cycle progression by downregulating CyclinD1 and upregulating P27. Cancer Biol Ther 6(10):1539-1545 (Pubitemid 351590324)
25. Lilley L, Schaffer S (1990) Human papillomavirus: a sexually transmitted disease with carcinogenic potential. Cancer Nurs 13(6):366-372
26. Lin CT, Chen CC, How SW, Huang WM, Peck K (1992) Localization of HPV-16 DNA sequence in CaSki cells by electron microscopic hybridocytochemistry. J Histochem Cytochem 40(4):467-473
27. Lin JC, Wu YY, Wu JY, Lin TC, Wu CT, Chang YL, Jou YS, Hong TM, Yang PC (2012) TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma. EMBO Mol Med 4(6):472-485
28. Liu T, Liu Y, Bao X, Tian J, Liu Y, Yang X (2013) Overexpression of TROP2 predicts poor prognosis of patients with cervical cancer and promotes the proliferation and invasion of cervical cancer cells by regulating ERK signaling pathway. PLoS One 8(9):e75864
29. Liu W, Yin T, Ren J, Li L, Xiao Z, Chen X, Xie D (2014) Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium. Eur Arch Otorhinolaryngol 271(2):265-273
30. Maclean J, Rybicki EP, Williamson AL (2005) Vaccination strategies for the prevention of cervical cancer. Expert Rev Anticancer Ther 5(1):97-107 (Pubitemid 40287440)
31. McDougall AR, Hooper SB, Zahra VA, Sozo F, Lo CY, Cole TJ, Doran T, Wallace MJ (2011) The oncogene Trop2 regulates fetal lung cell proliferation. Am J Physiol Lung Cell Mol Physiol 301(4):L478-L489
32. Ohmachi T, Tanaka F, Mimori K, Inoue H, Yanaga K, Mori M (2006) Clinical significance of TROP2 expression in colorectal cancer. Clin Cancer Res 12(10):3057-3063 (Pubitemid 43837351)
33. Park DS, Selvey LA, Kelsall SR, Frazer IH (1993) Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. J Virol Methods 45(3):303-318
34. Pattillo RA, Hussa RO, Story MT, Ruckert AC, Shalaby MR, Mattingly RF (1977) Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196(4297):1456-1458 (Pubitemid 8122337)
35. Porter AG, Jänicke RU (1999) Emerging roles of caspase-3 in apoptosis. Cell Death Differ 6(2):99-104 (Pubitemid 29082297)
36. Raji R, Guzzo F, Carrara L, Varughese J, Cocco E, Bellone S, Betti M, Todeschini P, Gasparrini S, Ratner E, Silasi DA, Azodi M, Schwartz P, Rutherford TJ, Buza N, Pecorelli S, Santin AD (2011) Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. J Exp Clin Cancer Res 30:106
37. Reed JC, Zha H, Aime-Sempe C, Takayama S, Wang HG (1996) Structure-function analysis of Bcl-2 family proteins: regulators of programmed cell death. Adv Exp Med Biol 406:99-112
38. Sharp PA, Zamore PD (2000) Molecular biology: RNA interference. Science 287(5462):2431-2433
39. Shen Y, White E (2001) p53-dependent apoptosis pathways. Adv Cancer Res 82:55-84 (Pubitemid 32613382)
40. Srinivasula SM, Ahmad M, Fernandes-Alnemri T, Alnemri ES (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell 1(7):949-957 (Pubitemid 128379256)
41. Stepan LP, Trueblood ES, Hale K, Babcook J, Borges L, Sutherland CL (2011) Expression of Trop2 cell surface glycoprotein in normal and tumor tissues: potential implications as a cancer therapeutic target. J Histochem Cytochem 59(7):701-710
42. Stoyanova T, Goldstein AS, Cai H, Drake JM, Huang J, Witte ON (2012) Regulated proteolysis of Trop2 drives epithelial hyperplasia and stem cell self-renewal viat β-catenin signaling. Genes Dev 26(20):2271-2285
43. Syrjänen KJ, Syrjänen SM (1985) Human papilloma virus (HPV) infections related to cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma of the uterine cervix. Ann Clin Res 2:45-56
44. Tetsu O, McCormick F (1999) Beta-catenin regulates expression of cyclinD1 in colon carcinoma cells. Nature 398(6726):422-426 (Pubitemid 29180374)
45. Trerotola M, Cantanelli P, Guerra E, Tripaldi R, Aloisi AL, Bonasera V, Lattanzio R, de Lange R, Weidle UH, Piantelli M, Alberti S (2013a) Upregulation of Trop-2 quantitatively stimulates human cancer growth. Oncogene 32(2):222-233
46. Trerotola M, Jernigan DL, Liu Q, Siddiqui J, Fatatis A, Languino LR (2013b) Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions. Cancer Res 73(10):3155-3167
47. Tyler M, Tumban E, Chackerian B (2014) Second-generation prophylactic HPV vaccines: successes and challenges. Expert Rev Vaccines 13(2):247-255
48. Varughese J, Cocco E, Bellone S, Ratner E, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Buza N, Pecorelli S, Santin AD (2011) Cervical carcinomas overexpress human trophoblast cellsurface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody. Am J Obstet Gynecol 205(6):567.e1-7
49. Warner CA, McCance DJ (1989) Screening for cervical carcinoma. Med Lab Sci 46(3):215-222 (Pubitemid 19192391)
50. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292(5517):727-730 (Pubitemid 32385543)
51. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275(5303):1129-1132 (Pubitemid 27097312)